Dow Chemical's Liveris urges support for better estimates of regulatory costs

05/28/2013 | Hill, The

The Business Roundtable is rallying support for a bill that would require more stringent cost studies for new regulations. "U.S. businesses, both small and large, are increasingly threatened by the accumulation of regulations over the last several decades," said Dow Chemical Chairman and CEO Andrew Liveris, who also chairs the business group's Select Committee on Smart Regulation. "This legislation is critical to streamlining and simplifying unnecessarily complex, redundant and sometimes contradictory regulations that can stall the engine of our economy," he added.

View Full Article in:

Hill, The

Published in Brief: